Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03893175 · ClinicalTrials.gov registry record · Phase 1
Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction
A Phase 1 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 1
- Development phase
- 86
- Enrollment target
NCT03893175: Completed Phase 1 study, sponsored by University of Pennsylvania.
NCT03893175 is a Phase 1 study that has completed, run by University of Pennsylvania. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03893175, a Phase 1 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 86 participants
- Enrollment target
Study Summary
This research study will evaluate inter-individual variability in the analgesic response to the non-steroidal anti-inflammatory drug (NSAID) ibuprofen after third molar extraction surgery. It will also investigate demographic, clinical, genetic, and environmental factors that cause this variability.
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2022-03-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03893175
The ClinicalTrials.gov registry entry for NCT03893175 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03893175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03893175 about?
NCT03893175 is a clinical study titled "Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction". This research study will evaluate inter-individual variability in the analgesic response to the non-steroidal anti-inflammatory drug (NSAID) ibuprofen after third molar extraction surgery. It will also investigate demographic, clinical, genetic, and environmental factors that cause this variability.
What is the current status of trial NCT03893175?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 86 participants. The study started on 2019-05-10. Estimated completion is 2022-03-02.
What interventions are being tested in trial NCT03893175?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Ibuprofen (DRUG), Oxycodone (DRUG).
Who is sponsoring clinical trial NCT03893175?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.